Global Obesity Treatment Market By Surgery Type(Adjustable gastric banding, Roux-en-Y gastric bypass, Sleeve gastrectomy, and Others) By Drug Type (Appetite suppressants, Combination drugs, Malabsorption drugs, Satiety drugs) End-Use(By Hospitals, Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview

The Obesity Treatment Market size is expected to be worth around USD 58.3 Billion by 2033 from USD 14.9 Billion in 2023, growing at a CAGR of 14.6% during the forecast period from 2024 to 2033.

Obesity is the increase in excessive or abnormal fat in the body, which causes a health risk. Obesity is linked to chronic diseases such as diabetes, orthopedic disorder, high blood pressure, and cancer. The growing rate of overweight individuals is responsible for the spread of chronic diseases.

Weight management programs and the increase in government initiatives targeting obesity’s harmful health effects are driving demand for technologically advanced weight-loss equipment, while flourishing gym culture, cosmetic concerns among millennials, weight-loss surgery as a method for treating excess body mass index (BMI), healthcare cost increases present opportunities to grow the global market further.

World Health Organization (WHO) defines overweight and obesity as abnormal or excessive accumulations of fat, raising risks such as insulin resistance, glucose intolerance, hypertension, sleep apnea, diabetes mellitus, arthritis gall bladder diseases and certain cancers. With rising rates of obesity prevalence comes an increased burden from chronic debilitating diseases that impede daily function severely reducing lifespan significantly – this epidemic of disease impacts us all.

Hence, there is an increased need for effective obesity treatment solutions to reduce the risk of chronic disorders. Several therapy solutions are available for weight loss, such as exercise, medications, invasive surgery, and devices. Obesity involves several genetic and physiological factors responsible for the growth of the disease.

Key Takeaways

• Market Size & Growth: Obesity Treatment Market size is expected to be worth around USD 58.3 Billion by 2033 from USD 14.9 Billion in 2023, growing at a CAGR of 14.6%
• Surgery Type Analysis: The Roux-en-Y Gastric Bypass held the 25.9% in the obesity treatment market.
• Drug Type Analysis: Appetite suppressants segment dominating 36.4% market share in 2023.
• End-Use Analysis: The hospital segment is dominating of 63.2% market share in the obesity treatment market.
• Regional Analysis: North America is dominating 42.7% share And holding USD 6.016 Billion in the obesity treatment market.
• Approaches to Treating Obesity: Obesity treatment may employ several strategies, including lifestyle modifications, medications and surgical interventions. The right choice depends on both severity of obesity as well as individual considerations regarding individual health needs and considerations.
• Technological Adoption: As technology becomes an ever-more integral component of obesity treatment, innovations like digital solutions, apps and wearable devices play a pivotal role in monitoring and optimizing treatment efficacy.

Surgery Type Analysis

Roux-en-Y Gastric Bypass Held the most significant Shares in the Obesity Treatment Market

Based on surgery type, the market is segmented into adjusting gastric banding, biliopancreatic diversion with duodenal switch, sleeve gastrectomy, roux-en-y gastric bypass, and other surgery types. The Roux-en-Y Gastric Bypass held the 25.9% in the obesity treatment market. The Roux-en-Y Gastric Bypass is one of the best solutions for losing weight or average weight loss around the year.

Several government activities about the problems, such as technological development in the healthcare sector, overweight, and easy availability of weight gain treatments, drive the obesity treatment market. Also, introducing advanced technologies with minimum side effects is the major focus of many companies. The researchers have been trying to renew white blood cells to work more like the brown fat cells. If this idea succeeds, they can efficiently treat the body’s fat-burning process.

Drug Type Analysis

Appetite Suppressants Held the Largest Shares in Drug Type Segment

Based on drug type, the market is segmented into combination drugs, appetite suppressants, malabsorption, and satiety drugs. Appetite suppressants segment dominating 36.4% market share in 2023. Appetite suppressants work by suppressing hunger; it helps to reduce weight loss by reducing food consumption. Doctors recommend Orlistat drug for weight loss.

The doctors refer the drug only when in cases in which patients fail to lose weight even after taking proper diet and physical exercise, and their weight threatens the patients’ health. There is no substitute for lifestyle changes, even orlistat also. The orlistat shows some side effects involving gastrointestinal problems, headaches, and irregular urination. Patients can lose weight by taking a low-calorie diet with proper drug treatment.

End-Use Analysis

The hospital segment Dominates the Obesity Treatment Market.

Based on end-user, the market is segmented into clinics and hospitals. The hospital segment is dominating of 63.2% market share in the obesity treatment market. Due to healthcare facilities and infrastructure, advanced technology in the hospitals.

The increase in obese patients and increased demand for advanced treatment in the presence of skilled professionals will help expand this segment. Furthermore, due to an increase in patient visits with innovative research in this sector, there is an increase in the growth of the obesity treatment market during the forecast period.

Key Market Segments

Surgery Type

• Adjustable gastric banding
• Roux-en-Y gastric bypass
• Sleeve gastrectomy
• Biliopancreatic diversion with duodenal switch
• Endoscopic procedures
• Others

Drug Type

• Appetite suppressants
• Combination drugs
• Malabsorption drugs
• Satiety drugs

End-Use

• Hospitals
• Clinics

Drivers

Changing Lifestyles and Diets, Peoples Drive the Growth of the Obesity Treatment Market

Many peoples change their lifestyle, which involves sleeping less, eating an unhealthy diet, and drinking such factors helps to increase obesity. It is a significant factor driving the market growth during the forecast period. The increase in government activities to detect the problems of lower weight people and increase in advanced development and effective weight control therapies. UK government announced new rules and regulations to control obesity, and the Better Health company encourages people to lose weight to improve their health.

Motivating individuals for better health is one of the best goals; it will help to drive the obesity treatment market growth. The advanced development in technologies and therapies such things helps the expansion of the obesity treatment market. Due to medical organization and their efforts obesity treatment market is estimated to grow during the forecast period.

The obesity treatment market is significantly growing by increasing awareness of sickness in all developing countries. Increasing weight control programs and creating a website that gives proper guidance to people such activities create awareness about the risk of being overweight such factors drive the growth of the obesity treatment market.

Restraints

Expensive Treatments and Drugs Restrict the Growth of Market

The expensive drugs and treatments may restrict the growth of the obesity treatment market. The weight loss treatment is not refunded in developing countries. Obesity treatment is a time-consuming process that will hamper market growth. The concerns about obesity drug treatment are the reason for conducting clinical trials. In addition, the adverse effects of the weight management drugs, such as diarrhea and nausea and lack of combination treatments, may restrict the market growth.

Opportunity

Advanced Treatments and Awareness Programs in Obesity Treatment Market

The expanding healthcare sectors in several emerging economic areas contribute to an increase in the global obesity treatment market. The growth in the geriatric population, rise in patient numbers, and growing awareness among individuals are helping expand healthcare industries worldwide. The expansion of the healthcare sector is significantly impacted by increasing awareness about sickness in developing regions.

Increasing weight control activities, all plications which help to direct right track to perform an individual’s regular activity and stop being overweight which is very dangerous for the health. The increase in investment in this sector is anticipated to provide market growth opportunities through an increase in the number of applications of the obesity treatment market in healthcare industries; increasing investment in this market is expected to offer growth opportunities.

Trends

Use of Orlistat for the Treatment of Obesity

Obesity poses a considerable challenge for both middle and low-income economies; according to WHO, being overweight is associated with several diseases, leading to higher mortality rates than undernutrition. The high prevalence of chronic diseases, diabetes, hypertension, and orthopedic disease is associated with being overweight. They are also choosing a poor lifestyle, unhealthy food, and lack of physical activity responsible for the weight gain.

Appetite suppressants are the type of supplements that work by reducing the appetite with weight loss and decreasing food consumption. Individuals use therapies to reduce high-calorie diets. Orlistat does not help with the changing lifestyle. It shows various side effects, such as gastrointestinal symptoms and headaches. Also, the gastric band is used by doctors to make the stomach smaller. After the operation, patients cannot consume more food in sitting, which considerably helps to reduce food intake.

Regional Analysis

North America is Most Dominating Region During the Forecast Period

North America is dominating 42.7 share And holding USD 6.016 Billion in the obesity treatment market. Easy accessibility of increasing investments in advanced technology and an increase in R&D activities are the main factors that help expand the obesity treatment market. The increasing prevalence of chronic diseases and obesity in people will help the growth of these regions.

Also, there is increasing awareness about healthy diet and exercise for good health, rising facilities for exercise, and an increase in disposable income in this region. Asia Pacific is also increasing their focus on obesity treatment. Asia Pacific provides health care facilities and infrastructure, raising awareness about the harmful effects of obesity and increasing medical tourism; all factors help to boost the obesity market growth in these regions.

Asia Pacific offers tremendous potential to the key market players to expand the market. Also, these regions give the market players a chance to launch their effective products. Increase in customer base and manufacturers quickly expanding their business in this sector. Brazil is expected to provide an attractive market potential for weight loss and management of diet for better health during the projection period due to the increase in the prevalence of obesity in these regions.

Key Regions

North America

• The US
• Canada
• Mexico

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica
• Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• Rest of MEA

Key Players Analysis

Emerging key players are focused on various strategic policies to develop their respective businesses in foreign markets. As a result, several obesity treatment market companies are expanding their operations and R&D facilities.

Furthermore, businesses in the obesity treatment market are developing new products and portfolio expansion strategies through investments, mergers, and acquisitions. In addition, several key players are now focusing on different marketing strategies, such as spreading awareness about natural ingredients and boosting the target products’ growth.

With many local and regional players, the market for global obesity treatment is fragmented. Market players are subject to intense competition from top players, particularly those with strong brand recognition and high distribution networks. As a result, companies have gained various expansion strategies, such as partnerships and product launches, to stay on top of the market.

Market Key Players

Listed below are some of the most prominent obesity treatment market players.

• AbbVie Incorporation,
• Medtronic PLC
• F. Hoffmann-La Roche, Ltd.
• Apollo Endosurgery, Inc.
• Arena Pharmaceuticals, Incorporation,
• Brunswick Corporation, C.H.
• Boehringer Sohn AG & Ko. KG,
• Herbalife Ltd.
• Johnson & Johnson Services, Inc.
• Other Key Players

Recent Developments

• In February 2022: Pfizer’s Research on an oral diabetes drug called The glucagon-like peptide-1 receptor as an oral diabetes drug suggested by Pfizer research that this drug can support managing type-2 diabetes and benefit weight loss since obesity is frequently associated with type 2 diabetes.
• In November 2021: Novo Nordisk declared that the European regulator, the Agency for Medicinal Products for Human Usage, has approved a favorable opinion and suggested marketing authorization of Wegovy for Chronic Weight management in obese adults.